Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEVRON CORPCVX · Entity 2804 | Director | March 01, 2006 | March 03, 2006 |
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | May 06, 2016 | May 10, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEVRON CORP
Report date March 01, 2006 · Filed March 03, 2006
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 371 |
Reported balance
After 2006-03-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2006-03-01 · Other · Acquired 371 · Balance 371 F1: The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service. F2: 1-for-1 F3: This number includes dividend equivalent accruals under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service.
F2: 1-for-1
F3: This number includes dividend equivalent accruals under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan.
GILEAD SCIENCES, INC.
Report date May 06, 2016 · Filed May 10, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 39,285 |
Reported balance
After 2016-05-06 transaction · row 1
1 source rowRow 1 · 2016-05-06 · Exercise / conversion · Acquired 1,466 · Balance 39,285 F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2016-05-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-05-06 · Exercise / conversion · Disposed 1,466 · Balance 0 F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: 100% of the restricted stock units vested on May 6, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2: 100% of the restricted stock units vested on May 6, 2016.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2016 Filed May 10, 2016 20:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 1,466 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-051680 · form4.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,466 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 6, 2016. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 6, 2016. Read SEC document |
| May 06, 2016 Filed May 10, 2016 20:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 1,466 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-051680 · form4.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| March 30, 2016 Filed Apr 1, 2016 19:29 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 10.0961 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-048081 · form4.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,169.4995 Underlying: Common Stock · 10.0961 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| December 30, 2015 Filed Jan 4, 2016 23:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 9.051 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-016953 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,159.4034 Underlying: Common Stock · 9.051 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| September 29, 2015 Filed Oct 1, 2015 20:49 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 9.5888 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-013514 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150.3524 Underlying: Common Stock · 9.5888 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| June 29, 2015 Filed Jul 1, 2015 22:50 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 7.9435 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-010628 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,140.7636 Underlying: Common Stock · 7.9435 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| May 06, 2015 Filed May 7, 2015 21:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 5,167 | $0.00 Strike: $102.27 | $0.00 |
DisclosureSEC source: 0001179110-15-007264 · edgar.xml · derivative · entry 4 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,167 Underlying: Common Stock · 5,167 shares Expires 2025-05-06 F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 06, 2015 Filed May 7, 2015 21:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 1,466 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-15-007264 · edgar.xml · derivative · entry 3 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,466 Underlying: Common Stock · 1,466 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 05, 2015 Filed May 7, 2015 21:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Units · Derivative | 1,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-15-007264 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,904 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F4 · derivative.exercise_date: 100% of the restricted stock units vested on May 5, 2015. F4 · derivative.expiration_date: 100% of the restricted stock units vested on May 5, 2015. Read SEC document |
| May 05, 2015 Filed May 7, 2015 21:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 1,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-15-007264 · edgar.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 07, 2014 Filed May 9, 2014 00:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 4,868 | $0.00 Strike: $78.77 | $0.00 |
DisclosureSEC source: 0001179110-14-008004 · edgar.xml · derivative · entry 4 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,868 Underlying: Common Stock · 4,868 shares Expires 2024-05-07 F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 07, 2014 Filed May 9, 2014 00:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 1,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-14-008004 · edgar.xml · derivative · entry 3 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,904 Underlying: Common Stock · 1,904 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 06, 2014 Filed May 9, 2014 00:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Units · Derivative | 2,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-14-008004 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F4 · derivative.exercise_date: 100% of the restricted stock units vested on May 6, 2014. F4 · derivative.expiration_date: 100% of the restricted stock units vested on May 6, 2014. Read SEC document |
| May 06, 2014 Filed May 9, 2014 00:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 2,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-14-008004 · edgar.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 10, 2013 Filed May 14, 2013 22:22 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Units · Derivative | 5,852 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-13-008382 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,863 Underlying: Common Stock · 5,852 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 10, 2013, at the end of the first year of service. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 10, 2013, at the end of the first year of service. Read SEC document |
| May 10, 2013 Filed May 14, 2013 22:22 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 5,852 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-13-008382 · edgar.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 08, 2013 Filed May 10, 2013 22:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 2,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-13-008228 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,715 Underlying: Common Stock · 2,863 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2014, or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2014, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 08, 2013 Filed May 10, 2013 22:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 8,442 | $0.00 Strike: $52.38 | $0.00 |
DisclosureSEC source: 0001179110-13-008228 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,442 Underlying: Common Stock · 8,442 shares Expires 2023-05-08 F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 8, 2014, or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 12, 2012 Filed May 16, 2012 00:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Units · Derivative | 3,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-12-008474 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,926 Underlying: Common Stock · 3,632 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 12, 2012, at the end of the first year of service. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 12, 2012, at the end of the first year of service. Read SEC document |
| May 12, 2012 Filed May 16, 2012 00:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 3,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-12-008474 · edgar.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 10, 2012 Filed May 15, 2012 00:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 2,926 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-12-008418 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,558 Underlying: Common Stock · 2,926 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on May 10, 2013, at the end of the first year of service. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on May 10, 2013, at the end of the first year of service. Read SEC document |
| May 10, 2012 Filed May 15, 2012 00:21 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 8,161 | $0.00 Strike: $51.25 | $0.00 |
DisclosureSEC source: 0001179110-12-008418 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,161 Underlying: Common Stock · 8,161 shares Expires 2022-05-10 F1 · derivative.exercise_date: Options vest quarterly over the first year of service and will be fully vested on May 10, 2013. Read SEC document |
| May 12, 2011 Filed May 14, 2011 01:02 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 3,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-11-007986 · edgar.xml · derivative · entry 3 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,632 Underlying: Common Stock · 3,632 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on May 12, 2012, at the end of the first year of service. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on May 12, 2012, at the end of the first year of service. Read SEC document |
| May 12, 2011 Filed May 14, 2011 01:02 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 10,141 | $0.00 Strike: $41.29 | $0.00 |
DisclosureSEC source: 0001179110-11-007986 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,141 Underlying: Common Stock · 10,141 shares Expires 2021-05-12 F1 · derivative.exercise_date: Options vest quarterly over the first year of service and will be fully vested on May 12, 2012. Read SEC document |
| May 11, 2011 Filed May 14, 2011 01:02 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Units · Derivative | 3,820 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-11-007986 · edgar.xml · derivative · entry 4 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F4 · derivative.exercise_date: 100% of the restricted stock units vested on May 11, 2011, at the end of the first year of service. F4 · derivative.expiration_date: 100% of the restricted stock units vested on May 11, 2011, at the end of the first year of service. Read SEC document |
| May 11, 2011 Filed May 14, 2011 01:02 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 3,820 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-11-007986 · edgar.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 11, 2010 Filed May 13, 2010 23:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 3,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-008592 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,820 Underlying: Common Stock · 3,820 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on May 11, 2011, at the end of the first year of service. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on May 11, 2011, at the end of the first year of service. Read SEC document |
| May 11, 2010 Filed May 13, 2010 23:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 10,860 | $0.00 Strike: $39.26 | $0.00 |
DisclosureSEC source: 0001179110-10-008592 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,860 Underlying: Common Stock · 10,860 shares Expires 2020-05-11 F1 · derivative.exercise_date: Options vest quarterly over the first year of service and will be fully vested on May 11, 2011. Read SEC document |
| May 06, 2010 Filed May 10, 2010 21:49 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantCommon Stock | 3,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-008262 · edgar.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,148 F1 · shares: Issuance of common stock upon vesting of certain restricted share units on May 6, 2010. Read SEC document |
| July 24, 2009 Filed Jul 28, 2009 22:29 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | PurchaseCommon Stock | 2,500 | $48.28 | $120,700.00 |
DisclosureSEC source: 0001179110-09-011235 · edgar.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,742 Read SEC document |
| May 06, 2009 Filed May 8, 2009 23:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Units · Derivative | 3,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-09-007484 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,406 Underlying: Common Stock · 3,406 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on May 6, 2010, at the end of the first year of service. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on May 6, 2010, at the end of the first year of service. Read SEC document |
| May 06, 2009 Filed May 8, 2009 23:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 9,534 | $0.00 Strike: $44.03 | $0.00 |
DisclosureSEC source: 0001179110-09-007484 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,534 Underlying: Common Stock · 9,534 shares Expires 2019-05-06 F1 · derivative.exercise_date: Options vest quarterly over the first year of service and will be fully vested on May 6, 2010. Read SEC document |
| May 08, 2008 Filed May 9, 2008 23:16 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $53.23 | $0.00 |
DisclosureSEC source: 0001179110-08-009318 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2018-05-08 F1 · derivative.exercise_date: Options vest quarterly over a period of one year from date of grant. Read SEC document |
| June 28, 2007 Filed Jul 2, 2007 19:26 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Shares · Derivative | 757.77 | $0.00 Strike: $39.59 | $0.00 |
DisclosureSEC source: 0001179110-07-014127 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757.77 Underlying: Common Stock · 757.77 shares Expires not disclosed F1 · derivative.exercise_price: All shares and dollar amounts reflect a two-for-one split that was effected on June 22, 2007 benefiting all shareholders of record as of May 24, 2007. F2 · derivative.exercise_date: The shares of phantom stock are fully vested, and at the election of the reporting person, become payable in common stock once the reporting person ceases to be a member of Gilead's Board of Directors. F2 · derivative.expiration_date: The shares of phantom stock are fully vested, and at the election of the reporting person, become payable in common stock once the reporting person ceases to be a member of Gilead's Board of Directors. Read SEC document |
| May 09, 2007 Filed May 11, 2007 23:23 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $82.82 | $0.00 |
DisclosureSEC source: 0001179110-07-009860 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2017-05-09 F1 · derivative.exercise_date: Options vested in full on May 9, 2007, the date of grant. Read SEC document |
| May 08, 2007 Filed May 11, 2007 23:23 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $82.96 | $0.00 |
DisclosureSEC source: 0001179110-07-009860 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2017-05-08 F2 · derivative.exercise_date: Options vested in full on May 8, 2007, the date of grant. Read SEC document |
| May 08, 2007 Filed Jun 21, 2007 22:23 UTC Amendment | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom shares · Derivative | 17.86 | $0.00 Strike: $82.82 | $0.00 |
DisclosureSEC source: 0001179110-07-013658 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17.86 Underlying: Common Stock · 17.86 shares Expires not disclosed F1 · derivative.exercise_date: The shares of phantom stock are fully vested, and at the election of the reporting person, become payable in common stock once the reporting person ceases to be a member of Gilead's Board of Directors. F1 · derivative.expiration_date: The shares of phantom stock are fully vested, and at the election of the reporting person, become payable in common stock once the reporting person ceases to be a member of Gilead's Board of Directors. Read SEC document |
| April 24, 2007 Filed Apr 25, 2007 21:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | PurchaseCommon Stock | 121 | $83.20 | $10,067.20 |
DisclosureSEC source: 0001179110-07-008374 · edgar.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121 Read SEC document |
| January 22, 2007 Filed Jan 24, 2007 20:29 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom shares · Derivative | 136.46 | $0.00 Strike: $64.25 | $0.00 |
DisclosureSEC source: 0001179110-07-001842 · edgar.xml · derivative · entry 2 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136.46 Underlying: Common Stock · 136.46 shares Expires not disclosed F3 · derivative.exercise_date: The shares of phantom stock are fully vested, and at the election if the reporting person, become payable in common stock once the reporting person ceases to be a member of Gilead's Board of Directors. F3 · derivative.expiration_date: The shares of phantom stock are fully vested, and at the election if the reporting person, become payable in common stock once the reporting person ceases to be a member of Gilead's Board of Directors. Read SEC document |
| January 22, 2007 Filed Jan 24, 2007 20:29 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $65.58 | $0.00 |
DisclosureSEC source: 0001179110-07-001842 · edgar.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2017-01-22 F1 · shares: Granted pursuant to the Gilead Sciences, Inc. 2004 Equity Incentive Plan in a transaction exempt from Rule 16b-3. F2 · derivative.exercise_date: Options will vest annually over a period of two years from January 22, 2007, the date of grant. Read SEC document |
| March 01, 2006 Filed Mar 3, 2006 18:05 UTC | CHEVRON CORP CVX · Entity 2804 | OtherPhantom Stock · Derivative | 371 | $57.35 Strike: $0.00 | $21,276.85 |
DisclosureSEC source: 0001127602-06-000429 · form4.xml · derivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371 Underlying: Common Stock · 371 shares Expires not disclosed F1 · security: The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service. F2 · derivative.exercise_price: 1-for-1 F1 · derivative.exercise_date: The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service. F1 · derivative.expiration_date: The shares of phantom stock issued under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan become payable in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service. F3 · balance_after: This number includes dividend equivalent accruals under the Chevron Non-Employee Directors' Equity Compensation and Deferral Plan. Read SEC document |
| April 27, 2005 Filed Apr 29, 2005 17:10 UTC | CHEVRON CORP CVX · Entity 2804 | GrantCommon Stock | 3,280 | $52.00 | $170,560.00 |
DisclosureSEC source: 0001127602-05-001190 · form4.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,993 F1 · shares: This number represents stock units and restricted stock paid under the Non-Employee Directors' Equity Compensation and Deferral Plan. F2 · balance_after: This number includes the acquisition of 10,649 additional shares from both the September 10, 2004, 2-for-1 stock split of ChevronTexaco common stock and the dividend equivalent accruals under the Non-Employee Directors' Equity Compensation and Deferral Plan. Read SEC document |
| April 28, 2004 Filed Apr 29, 2004 21:42 UTC | CHEVRON CORP CVX · Entity 2804 | GrantCommon Stock | 1,672 | $91.74 | $153,389.28 |
DisclosureSEC source: 0000093410-04-000032 · edgar.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,064 F1 · shares: This number represents stock units or restricted stock paid under the Non-Employee Directors' Equity Compensation and Deferral Plan. F2 · balance_after: This number includes dividend equivalent accruals under the Non-Employee Directors' Equity Compensation and Deferral Plan. Read SEC document |
| May 22, 2003 Filed Dec 4, 2003 23:40 UTC Amendment | CHEVRON CORP CVX · Entity 2804 | GrantCommon Stock | 1,579 | $67.45 | $106,503.55 |
DisclosureSEC source: 0000093410-03-000018 · edgar.xml · nonDerivative · entry 1 HILLS CARLA A · CIK 0001194913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,126 F1 · shares: Effective January 1, 2002, the retainer paid to non-employee Directors was $100,000 per annum ($75,000 in cash and $25,000 in dollar denominated deferred stock units). The deferred stock units were credited to the non-employee Directors' accounts quarterly and reported on Form 4s in 2002 and through the 1st and 2nd quarter of 2003. Effective May 22, 2003, the deferred stock units were credited to the non-employee Directors' accounts in a lump sum. Therefore, the number of deferred stock units reported on the Form 4 filed May 22, 2003 was overstated by 191 deferred stock units (the allocations for the 1st and 2nd quarter of 2003). The reporting person is filing an amended Form 4 to reflect the correct number of deferred stock units owned as of May 22, 2003. F2 · balance_after: This number includes dividend equivalent accruals under the Non-Employee Directors' Equity Compensation and Deferral Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.